TABLE 2.

Reported cases of patients with a diagnosis of STIC at RRSO

Patient Number	Institution	Age	BRCA Status	Procedures	Nodal Sampling	Washings	Adjuvant Treatment (No. cycles)	Follow-Up
1	A8	64	BRCA1	TAH, BSO, omentectomy	None	Negative	Unknown	Unknown
2	B12	61	BRCA1	BSO	None	Negative	None	38 m ned
3	B	48	BRCA1	BSO	None	Negative	None	7 m ned
4	B	49	BRCA1	TAH, USO	None	None	None	87 m ned
5	C14	44	BRCA1	TAH, BSO	None	Negative	Carboplatin/ paclitaxel	Median PFS, 36 months
6	C	44	BRCA2	TAH, BSO, “staging”	Unknown	Positive	Carboplatin/ paclitaxel
7	C	66	BRCA2	TAH, BSO, staging	Unknown	Negative	Carboplatin/ Paclitaxel
8	D16–18	52	BRCA1	BSO	Unknown	Negative	None	Ned at surgery
9	D	46	BRCA1	BSO	Unknown	Negative	None	ned at surgery
10	D	53	BRCA1	BSO	None	Negative	None	99 m ned
11	D	45	BRCA1	BSO	None	Negative	None	80 m ned
12	D	47	BRCA1	LAVH, BSO	None	Positive	Carboplatin/ paclitaxel (6)	150 m ned
13	D	46	BRCA2	BSO	None	Negative	Carboplatin/ Paclitaxel (3)	58 m ned
14	D	65	BRCA2	LAVH, BSO	None	Negative	Carboplatin/ paclitaxel (3)	138 m ned
15	E19,20	48	BRCA1	BSO	None	Negative	None	Ned at surgery
16	E	40	BRCA1	BSO	None	Negative	None	Ned at surgery
17	E	67	BRCA1	BSO	None	Negative	None	Ned at surgery
18	E	43	BRCA1	TLH, BSO, omentectomy	None	Positive	None	40 m ned
19	E	60	BRCA2	BSO	None	Suspicious	None	24 m ned
20	E	60	BRCA2	BSO	None	Negative	None	12 m ned
21	E	60	unknown high risk family history	BSO	None	Negative	None	48 m ned
22	E	44	unknown high risk family history	BSO	None	Negative	None	Ned at surgery
23	E	55	unknown high risk family history	TLH, BSO, omx	None	Positive	None	28 m ned
24	F20	44	BRCA1	BSO	None	None	None	Primary peritoneal carcinoma, 72 m
25	G21	57	BRCA2	Unknown	Unknown	Negative		26 m ned
26	G	50	BRCA2	Unknown	Unknown	Negative		8 m ned
27	G	56	BRCA2, variant of unknown significance	Unknown	Unknown	Negative		2 m ned
28	H18,22,23	51	BRCA1	BSO, omental biopsies	None	Negative	None	88 m ned
29	H	52	BRCA1	BSO, omental biopsies	None	Positive	None	101 m ned
30	H	50	BRCA1	BSO, omental biopsies	None	Negative	None	64 m ned
31	H	43	BRCA2	BSO, omental biopsies	None	Negative	None	47 m ned
32	I18	73	BRCA1	no staging	None	Negative	None	133 m ned
33	I	54	BRCA1	no staging	None	Negative	None	40 m ned
34	I	49	BRCA1	no staging	None	Negative	None	Primary peritoneal carcinoma, 43 m
35	I	61	BRCA1	staging with nodes	Yes	Negative	None	99 m ned
36	I	58	BRCA1	staging with nodes	Yes	Negative	None	78 m ned
37	I	76	BRCA2	staging without nodes	None	Negative	None	75 m ned
38	J	44	BRCA1	TAH, omentectomy, PLND, biopsies	Yes	Negative	None	19 m ned
39	J	39	BRCA1	TAH, omentectomy, PPALND	Yes	Negative	None	20 m ned
40	J	65	BRCA1	TAH, omentectomy, PPALND, biopsies	Yes	Negative	None	29 m ned
41	J	44	BRCA1	TAH, omentectomy, PPALND, biopsies	Yes	Negative	None	30 m ned
42	J	45	BRCA1	TAH, omentectomy, PPALND, biopsies	Yes	Negative	None	26 m ned
43	J	67	BRCA2	BSO	None	Negative	None	33 m ned
44	J	50	BRCA2	Offered, declined	None	Negative	None	34 m ned
45	J	46	BRCA2	Offered, declined	None	Negative	None	20 m ned
46	J	68	BRCA2	Performed at outside hospital	None	Negative	None	41 m ned
47	J	77	BRCA2	TAH, omentectomy, biopsies	None	Positive	None	16 m ned
48	J	60	unknown high risk family history	offered, declined	None	Negative	None	23 m ned
49	J	47	unknown high risk family history	TAH, omentectomy, PPALND, biopsies	Yes	Negative	None	44 m ned